Track topics on Twitter Track topics that are important to you
The conference will focus on preparing the pharmaceutical and biopharmaceutical industry for a full transition to an end-to-end integrated computerized system throughout the manufacturing process.
Bethesda, Maryland (PRWEB) August 17, 2017
The International Society for Pharmaceutical Engineering (ISPE) announced its Europe Pharma 4.0 Conference, taking place 23 – 24 November in Verona, Italy. Organized in partnership with the ISPE Italy Affiliate, the conference will focus on preparing the pharmaceutical and biopharmaceutical industry for a full transition to an end-to-end integrated computerized system throughout the manufacturing process.
The introduction of advance automation and the increasing interconnectivity of Industry 4.0 is not only revolutionizing the Pharma industry, but also introducing many new challenges and production roadblocks.
“Shifting the paradigm to Pharma 4.0 and focusing on the issues specifically surrounding pharmaceutical priorities will lead to improvements in productivity, quality, and security of the supply chain,” said John Bournas, ISPE CEO and President. “The conference will explore the effects of this shift and how the industry will prepare for this next generational challenge.”
The ISPE 2017 Europe Pharma 4.0 Conference stems from the ISPE Europe Affiliates’ newly founded special interest group (SIG): “From Industry 4.0 to Pharma 4.0". The Pharma 4.0 SIG started discussions around the issues that the new “automation” factors are causing in the pharmaceutical production chain. Their goal is to specify and differentiate Pharma 4.0 from the common “Industry 4.0” concept, with the focus on maturity level models integrated in the program.
The two-day event features an education program focused on core topics, including automation, analytics, end-to-end integration, and workforce 4.0. Attendees will gain insight into a new world of manufacturing, engaging in dialogue with peer groups and senior industry leaders, and learning new manufacturing applications, models, and solutions.
To learn more about this event, visit http://www.ISPE.org/2017-Europe-Pharma-Industry-4-0-Conference.
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical life cycle. The more than 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland USA, and an operations and training center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.
For more information, contact:
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/08/prweb14611305.htmNEXT ARTICLE
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...